Genetic Variability in CYP3A4 and CYP3A5 in Cancer Patients
Author Information
Author(s): Gervasini Guillermo, García-Martín Elena, Ladero José M, Pizarro Rosa, Sastre Javier, Martínez Carmen, García Monserrat, Diaz-Rubio Manuel, Agúndez José AG
Primary Institution: University of Extremadura, Badajoz, Spain
Hypothesis
This study aims to examine associations between common CYP3A4 and CYP3A5 polymorphisms and digestive cancer risk.
Conclusion
Common polymorphisms on CYP3A4 and CYP3A5 genes do not modify the risk of developing digestive cancers in Western Europe.
Supporting Evidence
- The study included 574 individuals, with 411 being cancer patients.
- No significant differences in genotype frequencies were observed among the study groups.
- The study found similar allele frequencies for CYP3A4 and CYP3A5 across cancer patients and healthy controls.
Takeaway
The study looked at how certain genes might affect the risk of getting digestive cancers, but it found that these genes don't really change that risk.
Methodology
CYP3A4 and CYP3A5 genotypes were determined in 574 individuals including cancer patients and healthy controls.
Potential Biases
Potential bias due to the educational background of control subjects compared to cancer patients.
Limitations
The study may not account for all confounding factors related to diet and lifestyle differences between patients and controls.
Participant Demographics
Participants were white Spanish individuals, including 411 patients with digestive cancers and 163 healthy subjects.
Statistical Information
P-Value
0.051
Confidence Interval
95% C.I. 2.6–7.0
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website